View Post

Western Connecticut Health Network Site Launches Breast Cancer Clinical Trials through Collaboration with Memorial Sloan Kettering Cancer Center

In In The News by Barbara Jacoby

As part of a pioneering cancer-care collaboration between Norwalk Hospital and Memorial Sloan Kettering Cancer Center, clinical trials studying new breast cancer therapies are now open in Fairfield County. Four cutting-edge breast cancer clinical trials have launched at Norwalk Hospital, part of the Western Connecticut Health Network. The breast cancer clinical trials are an extension of Memorial Sloan Kettering Cancer …

View Post

Cancer docs say ‘superblood’ may work against deadly malignancies

In In The News by Barbara Jacoby

By: David Cox From: nbcnews.com Cancer care has seen its share of false dawns in recent years, with many new drugs failing to live up to their early promise. But now there’s great excitement over so-called “superblood” — red blood cells that have been chemically modified to deliver cancer-killing drugs like L-asparaginase, an enzyme that blocks the nutrients cancer cells …

View Post

Could THIS combination cure breast cancer? ‘

In In The News by Barbara Jacoby

By: Stephen Matthews From: dailymail.co.uk A combination of immunotherapy and a virus could treat aggressive breast cancer, an ‘absolutely amazing’ study has revealed. Breakthrough research showed the pairing cured up to 90 per cent of mice plagued by triple negative breast cancer – deemed the deadliest form. Canadian scientists are hopeful the findings will lead to a potential cure, as …

View Post

Researchers repurpose immune-activating cytokine to fight breast cancer

In In The News by Barbara Jacoby

Source: Case Western Reserve University From: sciencedaily.com The most lethal form of breast cancer could have a new treatment option, according to new research out of the Case Comprehensive Cancer Center at Case Western Reserve University School of Medicine. In the Proceedings of the National Academy of Sciences, researchers showed triple-negative breast cancer cells are highly vulnerable to interferon-β — …

View Post

Promising Research on New Way to Fight Breast Cancer

In In The News by Barbara Jacoby

Source: Vanderbilt University Research shows promise on new way to fight breast cancer Hijacking human proteins to better deliver anti-cancer drugs Powerful molecules can hitch rides on a plentiful human protein and signal tumors to self-destruct, a team of Vanderbilt University engineers found. Their research gives oncologists a better shot at overcoming the problems of drug resistance, toxicity to patients …

View Post

New compound boosts treatment for aggressive breast cancer

In In The News by Barbara Jacoby

By: Ana Sandoiu From: medicalnewstoday.com Although breast cancer survival rates are overall very high, some forms of cancer are more difficult to treat than others. However, a new compound proves highly effective against these types by targeting a protein that makes cancer cells resistant to treatment. Triple-negative breast cancer is often resistant to treatment. Its name refers to the hormone …

View Post

TapImmune Reaches 50% Patient Enrollment Benchmark in Phase 2 Study of Novel T-Cell Vaccine Targeting Triple-Negative Breast Cancer

In In The News by Barbara Jacoby

From: PR Newswire Enrollment Completion Anticipated by Year End 2017 TapImmune, Inc. (NASDAQ: TPIV), a clinical-stage immuno-oncology company specializing in the development of immunotherapies targeting women’s cancers, announced that it has enrolled 50% (40/80) of the patients in its randomized Phase 2 clinical study of its novel T-cell vaccine candidate TPIV 200 for treating triple-negative breast cancer (TNBC).  The four-arm …

View Post

Immunotherapy May Treat This Deadly Breast Cancer

In In The News by Barbara Jacoby

By: Alice Park From: time.com Triple negative breast cancer is one of the most difficult types of cancer to treat. It lacks proteins that can attract powerful anti-cancer and hormone drugs, so people diagnosed with the disease have to rely almost exclusively on chemotherapy. But in a new presentation at the annual American Association for Cancer Research meeting, researchers say …

View Post

Old-Style Chemo Is Still A Mainstay In The Age Of Targeted Cancer Therapy

In In The News by Barbara Jacoby

By: Richard Harris From: npr.org Chemotherapy remains one of the mainstays of cancer treatment, but these harsh drugs are slowly being edged aside in medical research, as new treatments, like immunotherapy, grab the spotlight. Still, this is not the end of the road for chemotherapy. For one thing, doctors are coming to realize that some of these drugs are useful …